Minor
IGT-303 in Healthy Volunteers and · Chronic Kidney Disease
Primary completion pushed from Oct 2026 to Dec 2026
Also in this update: Trial sites expanded: 5 → 13 locations; Study completion pushed from Jan 2027 to Apr 2027
Ingenia Therapeutics INCPhase 1/2 NCT07231679 Registry history of NCT07231679 on ClinicalTrials.gov (opens the registry)